The Psymposia Campaign Against Hamilton Morris: A Factual Review of the Claims

Background

In March 2026, the psychedelic journalism outlet Psymposia published a four-part series titled "Hamilton's Pharma Cope" targeting Hamilton Morris, the chemist, journalist, and creator of Hamiltons Pharmacopeia. The series makes serious allegations: that Morris called them DEA informants, spread conspiracy theories about their funding, and engaged in a coordinated smear campaign.

The series was published alongside a prequel episode critiquing Andrew Callaghan's Channel 5 coverage, in which Callaghan interviewed Morris about his concerns with Psymposia's reporting.

This article reviews the specific claims against the available evidence. It is not a defense of every word Morris has ever said. It is an examination of whether Psymposia's characterization of his statements is accurate.

The DEA Informant Claim

Psymposia's Part 1 centers on the allegation that Morris falsely claimed they were "DEA informants." This is the most serious charge, and the one most directly addressed by the Channel 5 interview.

In the Channel 5 interview, Morris does not use the phrase "DEA informants." What he actually says is that Psymposia has developed unusually close working relationships with regulatory agencies, particularly the FDA, and that their reporting appears coordinated with FDA enforcement actions against Lykos Therapeutics. The segment shows Morris expressing concern about conflicts of interest, not accusing anyone of being a law enforcement asset.

What Psymposia characterizes as "being called DEA informants" is more accurately described as Morris questioning whether the lines between journalism and advocacy, and between journalism and regulatory influence, have become blurred. This is a legitimate question about journalistic ethics.

The Channel 5 / Andrew Callaghan Connection

Psymposia's prequel episode critiques Andrew Callaghan's journalism. The claim that Callaghan "incites his audience to target and destroy Psymposia" requires examination.

In the Channel 5 piece, Callaghan interviews Morris about his concerns. The segment does not contain calls to action against Psymposia. It presents Morris's perspective alongside context about the broader psychedelic industry debate. Characterizing this as "incitement" misrepresents what was actually broadcast.

Funding Transparency

Part 3 focuses on what they describe as Morris's "conspiratorial claims" about their funding, specifically regarding Usona Institute. Morris has questioned whether Psymposia's funding sources create conflicts of interest.

This is not a fringe position. Psymposia's funding has been the subject of legitimate questions, their reporting on Lykos benefited competing interests in the psychedelic drug development space. Transparency about funding sources is standard journalistic practice. Asking about it is not a "conspiracy theory."

— Sponsored —

Protect your connection while traveling

The Personal Attacks

Part 4 moves from policy disagreements to personal attacks: that Morris lacks journalistic training, that he mistreated a former associate, and that he has engaged in character assassination.

The question of whether someone has formal "journalistic training" is largely irrelevant, many of the best journalists working today are self-taught. Morris's body of work, years of documentary journalism covering complex scientific and cultural topics, speaks for itself.

The allegations about his treatment of an associate (Justin Clark, profiled in New York Magazine) are serious and deserve to be taken seriously. But they are separate from the question of whether his criticisms of Psymposia's reporting are valid. Using one person's personal conduct to discredit their professional criticisms is a logical fallacy.

What This Dispute Actually Reveals

The dispute between Hamilton Morris and Psymposia is fundamentally about the role of journalism in the psychedelic industry. There is a growing tension between investigative journalism that scrutinizes all actors and advocacy journalism that sees its role as promoting legalization. These are different models with different standards, and the friction between them is predictable.

Conclusion

After reviewing the Psymposia series against the available evidence:

1. The claim that Morris called Psymposia "DEA informants" is not supported by the actual recordings of what he said
2. Questions about funding transparency and conflicts of interest are legitimate journalistic concerns, not conspiracy theories
3. Personal attacks about Morris's training or past are separate from the validity of his criticisms
4. The dispute reflects genuine tension between investigative and advocacy journalism in the psychedelic space

We encourage readers to watch the Channel 5 interview and read the Psymposia series for themselves and draw their own conclusions.

Note: This article presents our review of publicly available materials. Both parties in this dispute deserve to be judged on the accuracy of their claims, not the volume of their accusations.

Legal Disclaimer: This article is for informational and educational purposes only. It does not constitute legal advice, a legal opinion, or a definitive finding of fact regarding any claims made by or about any person or organization mentioned herein. The statements attributed to individuals are based on publicly available recordings, publications, and statements as of the date of publication. We have made reasonable efforts to verify the accuracy of the information presented, but we make no representations or warranties regarding its completeness or currentness. Readers are encouraged to independently verify all claims and consult qualified legal counsel for any legal questions or disputes. This content is protected as opinion and commentary under applicable defamation and free speech laws. TestSubstances.com assumes no liability for any actions taken based on the information in this article.